TRANSCRIPTIONAL ACTIVATION OF ?-CATENIN BY MIR-138 PROMOTES UP-REGULATION OF ALPHA-METHYLACYL-COA RACEMASE IN PROSTATE CANCER CELLS

被引：0
|
作者：
Erdmann, Kati
Kaulke, Knut
Fuessel, Susanne
Wirth, Manfred P.
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP70-15
引用
收藏
页码：E940 / E940
页数：1
相关论文
共 50 条
  • [1] Induction of alpha-methylacyl-CoA racemase by miR-138 via up-regulation of β-catenin in prostate cancer cells
    Kati Erdmann
    Knut Kaulke
    Christiane Rieger
    Manfred P. Wirth
    Susanne Fuessel
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 2201 - 2210
  • [2] Induction of alpha-methylacyl-CoA racemase by miR-138 via up-regulation of β-catenin in prostate cancer cells
    Erdmann, Kati
    Kaulke, Knut
    Rieger, Christiane
    Wirth, Manfred P.
    Fuessel, Susanne
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (11) : 2201 - 2210
  • [3] Alpha-methylacyl-CoA racemase and hepsin as urinary prostate cancer markers
    Sroka, Wiktor Dariusz
    Adamowski, Marek
    Slupski, Piotr
    Siodmiak, Joanna
    Jarzemski, Piotr
    Ordowaz-Sypniewska, Grazyna
    Marszall, Michal Piotr
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2015, 30 (04): : E401 - E406
  • [4] Alpha-methylacyl-coa racemase (AMACR)-based molecular imaging of prostate cancer
    Warlick, CA
    Pomper, MG
    Isaacs, WB
    De Marzo, AM
    Rodriguez, R
    JOURNAL OF UROLOGY, 2006, 175 (04): : 501 - 501
  • [5] Alpha-methylacyl-coa racemase (AMACR) variants and prostate cancer in plco.
    Daugherty, SE
    Platz, EA
    Fallin, MD
    Welch, R
    Reding, D
    Huang, WY
    Chatterjee, N
    Hayes, RB
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (11) : S150 - S150
  • [6] Alternative spliced variants of the alpha-methylacyl-CoA racemase gene and their expression in prostate cancer
    Mubiru, JN
    Shen-Ong, GL
    Valente, AJ
    Troyer, DA
    GENE, 2004, 327 (01) : 89 - 98
  • [7] Evaluation of alpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers
    Gumulec, J.
    Masarik, M.
    Krizkova, S.
    Hlavna, M.
    Babula, P.
    Hrabec, R.
    Rovny, A.
    Masarikova, M.
    Sochor, J.
    Adam, V.
    Eckschlager, T.
    Kizek, R.
    NEOPLASMA, 2012, 59 (02) : 191 - 200
  • [8] Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker
    Jiang, Z
    Wu, CL
    Woda, BA
    Iczkowski, KA
    Chu, PG
    Tretiakova, MS
    Young, RH
    Weiss, LM
    Blute, RD
    Brendler, CB
    Krausz, T
    Xu, JC
    Rock, KL
    Amin, MB
    Yang, XJ
    HISTOPATHOLOGY, 2004, 45 (03) : 218 - 225
  • [9] Use of alpha-methylacyl-CoA racemase (AMACR) in the diagnosis of prostate cancer (PCA) on needle biopsy.
    Demarzo, A
    Powell, EL
    Isaacs, WB
    Luo, J
    Wanders, RJ
    Gage, WR
    Hicks, J
    Epstein, JI
    JOURNAL OF UROLOGY, 2002, 167 (04): : 330 - 330
  • [10] Utility of immunohistochemistry for alpha-methylacyl-coa racemase (AMACR) in distinguishing atrophic prostate cancer from benign atrophy
    Farinola, MA
    Epstein, JI
    MODERN PATHOLOGY, 2003, 16 (01) : 149A - 149A
12345